Biotechs for biodefense :The Scientist [10/2/2003]

Front Cover

Advertisement

NRW: North Rhine-Westphalia

Survey Series

The Scientist Daily

Science headlines delivered daily.
Register today.

Institutions

For Advertisers

by Hannah Kamenetsky

Biotechs for biodefense

Email: Hannah Kamenetsky - hkamenetsky@mindspring.com
News from The Scientist 2003, 4(1):20030210-06 doi:10.1186/20030210-06

10 February 2003

Details of the President's Project BioShield, a $6 billion proposal to fast-track bioagent vaccines and treatments, have yet to be revealed, but the announcement alone has spurred a gold rush among biotech companies eager to get involved in the 10-year research-and-development initiative. In one of several such meetings coming up, biotech companies gathered at a conference in Maryland Thursday to find out how they can get a piece of the biodefense pie, including the latest new potential plum.


	The article you are attempting to read is Premium content which is only available to our online subscribers.

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today